Evidence-Based Medicine Guidelines
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcimimetics for Secondary Hyperparathyroidism in Chronic Kidney Disease Patients." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients.
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients. Accessed October 13, 2024.
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients
Calcimimetics for Secondary Hyperparathyroidism in Chronic Kidney Disease Patients [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
ID - 456360
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456360/all/Calcimimetics_for_secondary_hyperparathyroidism_in_chronic_kidney_disease_patients
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
